Artemisia annua L. essential oil (AAEO) has diverse properties including antibacterial, antioxidant, antinociceptive, and antimicrobial activities. However, the effect of AAEO on obesity remains to be investigated. In this study, we analyzed the compounds of AAEO and explored the effect of AAEO on the differentiation of preadipocyte into adipocyte using preadipocyte cell line 3T3-L1. Total yield of AAEO from 20 kg A. annua leaf and flower was 0.5%, v/w. Gas chromatography-mass spectrometry analysis showed that AAEO contained 34 compounds. 3T3-L1 cells incubated in 3-isobutyl-1-methylxanthine / dexamethasone / insulin (MDI)-containing medium showed increased accumulation of lipid droplets. This increased response was suppressed by treatment with AAEO. Expressions of obesity-related proteins (PPARγ, C/EBPα, SREBP-1c, FAS, and ACC) were increased in 3T3-L1 cells cultured in MDI medium and these responses were decreased by treatment with AAEO. These findings demonstrate that AAEO may suppress 3T3-L1 cell differentiation by inhibiting adipogenesis and activation of lipid metabolism-related proteins.
Obesity is caused by an imbalance between energy intake and expenditure and can be accompanied by various chronic diseases including hypertension, type 2 diabetes mellitus, and atherosclerosis [1] . Development of obesity is associated with the increment in adipocyte number [2] . Therefore, control of adipocyte differentiation or proliferation may be a strategy for the prevention and treatment of obesity and its related metabolic disorders. Adipocyte differentiation, a process of adipocyte formation from precursor cells, occurs in a series of stages (confluence, hormonal induction, clonal expansion, growth arrest, and terminal differentiation) [3] . Adipocyte differentiation is induced by two transcription factors, peroxisome proliferator-activated receptor γ (PPARγ) and CCATT/enhancer binding protein α (C/EBPα), known as regulators of adipocyte differentiation [4] . In addition, the adipogenic transcription factors modulate lipid metabolism-related enzymes including fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC) [5] . Sterol regulatory element binding protein (SREBP-1c) is a key transcription regulator of adipogenesis, increasing PPARγ activity during adipocyte differentiation [6, 7] . [8, 9] . Moreover, they have been reported to have fewer side effects compared with synthetic products [9] . Therefore, plant extracts and phytochemicals might be potential candidates for development of drug or dietary supplements to overcome obesity.
Many plant extracts and phytochemicals possess high potentials for obesity treatment and have been used as dietary supplements
Artemisia annua L. (family Asteraceae), an annual herb of tropical Asian origin, is widely distributed worldwide. In South Korea, the plant is commonly found growing in fields and by roadsides all over the country. A. annua has long been used in Chinese medicine. Extracts and essential oil of the plant contain various compounds including a flavonoid, coumarin, triterpenoids, phenolics, lipids, aliphatics, and sesquiterpenoids [10] [11] [12] . A. annua has been widely researched in the area of traditional herbal medicines since it was used as a source of the anti-malarial compound artemisinin and related compounds [13, 14] . In addition, Artemisia annua L. essential oil (AAEO) is known to have various biological effects including antibacterial, antioxidant, and antimicrobial activities [15, 16] . Some herbal essential oils have been used for control of obesity [17] [18] [19] . Nonetheless, there has been no information on the anti-obesity-related activity of AAEO so far. In the present study, we extracted AAEO and its chemical compounds were analyzed. To evaluate the anti-obesity-related activity of AAEO, we investigated the effect of AAEO on differentiation of preadipocytes into adipocytes using preadipocyte cell line 3T3-L1.
Total yield of AAEO from 20 kg A. annua leaf and flower was 0.5%, v/w. Results of gas chromatography-mass spectrometry (GC/MS) analysis showed that AAEO contained 34 compounds and that the main compounds were 1,8-cineole (20.6%), germacrene-D (19.3%), and caryophyllene (11.4%) ( Table 1 ). AAEO contained compounds that are known to exhibit inhibitory effects on the risk of obesity in animals, as well as unknown activities [20, 21] . Obesity is closely associated with increased differentiation of adipocytes [22] . These findings suggest the possibility that AAEO affects obesity through controlling differentiation of adipocytes. We thus explored the effects of AAEO on differentiation of a preadipocyte cell line, 3T3-L1, into adipocytes.
Adipocytes play an important role in maintaining energy homeostasis and lipid metabolism. In addition, they can be differentiated from 3T3-L1 preadipocytes by stimulation of several hormones and various transcription factors, resulting in accumulation of lipid in 3T3-L1 adipocytes [23] . However, whether AAEO influences adipocyte differentiation, which plays an important role in regulation of obesity, has not been reported. First, the effect of AAEO (0.110 μg/mL) on viability in 3T3-L1 cells was tested using the XTT assay. As shown in Figure 1 , AAEO did not influence viability in 3T3-L1 cells at concentrations of 0.1 and 1 μg/mL. However, significant inhibition of 3T3-L1 cell viabillity by AAEO was observed at concentrations of 5 to 10 μg/mL ( Figure 1 ). Thus, AAEO concentrations of 0.1 to 1 μg/mL were used for adipocyte differentiation-related tests. 3T3-L1 cells that are cultured in 3-isobutyl-1-methylxanthine/ dexamethasone/insulin (MDI)-containing medium differentiate to adipocytes, with increased accumulation of lipid during differentiation [24] . To test the effect of AAEO on adipogenic response, 3T3-L1 preadipocytes were incubated in MDI medium either with or without AAEO, and the levels of accumulated lipid droplets in the cells during differentiation were assessed by oil red-O staining. 3T3-L1 cells cultured in MDI medium showed increased accumulation of lipid droplets (Figure 2A and B ). This increased lipid accumulation was suppressed by treatment with AAEO (0.11 μg/mL) in a dose-dependent manner, which reached a maximal level at an AAEO concentration of 1 μg/mL (21.5±0.55% of response in MDI alone-treated state; n=4) ( Figure 2A and B ). On the other hand, 3T3-L1 cells cultured in the absence of MDI showed lesser accumulation of lipid droplets (22.5±1.3% of response in MDI alone-treated state; n=4) compared with those cultured in MDI and were not affected by treatment with 1 μg/mL of AAEO ( Figure  2A and B; n=4). These findings imply that AAEO has antiadipogenic activity, probably leading to its anti-obesity action, without cytotoxicity.
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To examine the effect of AAEO on expression of obesity-related proteins in adipocytes, Western blot assay was performed for obesity-related proteins in AAEO (0.11 μg/mL)-exposed 3T3-L1 adipocytes that were differentiated by culturing in MDI. The protein expressions of PPARγ, C/EBPα, SREBP-1c, FAS, and ACC were predominantly increased in 3T3-L1 preadipocytes cultured in MDI medium. Treatment with AAEO at a concentration of 0.1 μg/mL only attenuated expression of C/EBPα (83.15±3.91% of response in MDI alone-treated state), but not those of other proteins, among the MDI-increased proteins in 3T3-L1 adipocytes. (Figure 3; n=3 ). On the other hand, treatment with AAEO at a concentration of 0.5 and 1 μg/mL resulted in significantly decreased expression of all MDIincreased proteins in 3T3-L1 adipocytes, which showed maximal response at 1 μg/mL (PPARγ: 4.80±2.87%; C/EBPα: 6.20±2.67%; SREBP-1c; 19.86±6.49%; ACC: 0.56±0.38%; FAS: 7.44±6.37% of response in MDI alone-treated state; n=3, respectively) ( Figure 3 ). Obesity is known to be regulated by a variety of factors, including transcriptional factors and adipogenic marker genes [24, 25] . PPARγ and CEBPα are major transcriptional activators of adipocyte differentiation [4] and also contribute to the expression regulation of adipogenic-specific genes [26] . The level of lipid accumulation is induced by CEBPα mediated by PPARγ, controlling adipocytespecific gene expression [23] . This study showed that increased expression of PPARγ and CEBPα by treatment with MDI was suppressed in 3T3-L1 adipocytes in the presence of AAEO. Therefore, these reports and our findings suggest that AAEO may inhibit adipocyte differentiation mediated by PPARγ/CEBPα-linked adipogenesis pathways. SREBP-1c is the most plentiful class of SREBPs in the liver and adipose tissue and controls the genes involved in fatty acid synthesis [27] . In the current study, we showed that AAEO inhibited enhanced SREBP-1c expression in 3T3-L1 adipocytes treated with MDI. These results indicate that AAEO may affect fatty acid synthesis. In addition, FAS and ACC are known as adipogenesis-related genes and controlled by PPARγ and C/EBPα [25] . In the current study, AAEO attenuated MDI-increased expression of FAS and ACC. These reports indicate that AAEO may inhibit the expression of FAS and ACC through downregulation of adipogenic transcription factors, PPARγ/CEBPα, as well as fatty acid synthesis-related genes, consequentially leading to inhibition of lipid accumulation. Artemisia annua essential oil in adipocyte differentiation Natural Product Communications Vol. 11 (4) 2016 541 Therefore, AAEO may exert an inhibitory effect on differentiation of 3T3-L1 preadipocytes into adipocytes, probably via mechanisms including inhibition of the adipogenic transcription factors, PPARγ and CEBPα, and suppression of various adipogenic factors, SREBP-1c, FAS, and ACC. To the best of our knowledge, the current study provides the first evidence that AAEO might arrest adipocyte differentiation, probably resulting in inhibition of obesity.
In conclusion, the current study demonstrated that AAEO contained 34 compounds and suppressed accumulation of lipid droplets in response to MDI. In addition, treatment with AAEO inhibited the expression of obesity-related proteins (PPARγ, C/EBPα, SREBP-1c, FAS, and ACC) in 3T3-L1 cells cultured in MDI medium. We thus concluded that AAEO may inhibit differentiation through the downregulation of adipogenesis and lipid metabolism-related proteins in 3T3-L1 adipocytes. Therefore, the present study may provide valuable information for development of a potential agent to either prevent or treat obesity, although further investigations will be needed for the in vivo validation test of AAEO on obesity. Furthermore, the isolation and identification of a key bioactive AAEO component that exerts anti-differentiation activity in adipocytes will be an important target for future research to clarify the detailed action of AAEO.
Experimental

Extracts of AAEO:
Artemisia annua L. was cultivated on a practice farm at the Department of Cosmetic Science, Hoseo University, Asan (South Korea) and identified by Jong-Cheol Yang, Division of Forest Biodiversity and Herbarium, Korea National Arboretum, South Korea. A voucher specimen (No. AAEO-0001) is kept at the Herbarium of the College of Life and Health Sciences, Hoseo University. The leaves and flowers were harvested and air-dried for 24 h. The semi-dried leaves and flowers (20 kg) were subjected to conventional steam distillation for essential oil extraction. The obtained AAEO (100 mL) was stored at 4C in dark vials. In each experiment, AAEO was used after its solubilization by Transcutol-CG (0.1%, v/v), which is widely used as a non-cytotoxic solubilization agent in cosmetics.
Compound analysis and identification of AAEO:
The components of the AAEO were confirmed at the Korean Basic Science Institute (KBSI, Seoul, Korea) and identified by GC/MS. GC/MS analysis was performed using an Agilent 6890N GC/5975i MS instrument (Palo Alto, CA, USA) and a DB5-MS capillary column (30 m × 250 μm, 0.25 μm film thickness). The carrier gas was helium with a flow rate of 1 mL/min. The injector port and interface temperature were 280 and 300C, respectively. GC oven temperature was kept at 40C for 2 min and programmed to 230C at a rate of 5C /min, and then kept constant at 300C for 5 min. The split ratio was 1:10. The mass ranges were from m/z 40 to 800. Retention indices (RI) for all compounds were determined according to the Kovats method using standard C 7 -C 40 n-alkanes [28] . The compounds were identified by comparison of their RI with those of Adams indices and by matching their MS fragmentation patterns with those of the Wiley7NIST 0.5 L Mass Spectral library and catalogs for mass spectra. Cell culture and differentiation: 3T3-L1 preadipocytes (American Type Culture Collection, Manassas, VA, USA) were cultivated in a 150 mm dish with DMEM containing 10% NCS and 1% P/S in a 5% CO 2 atmosphere at 37°C and were grown to more than 80-90% confluence. Following incubation for 2 days (differentiation day 0), for induction of adipocyte differentiation, the cells were cultivated in differentiation medium containing 3-isobutyl-1-methylxanthine (0.5 mM), dexamethasone (1 M), and insulin (5 g/mL) (MDI) for 2 days (differentiation day 2) in DMEM with 10% FBS. Cells were then maintained in DMEM supplemented with 10% FBS and 5 µg/mL insulin for another 2 days (differentiation day 4), followed by culturing with DMEM containing 10% FBS for an additional 4 days (differentiation day 8).
Materials
Cell viability assay:
Cell viability was measured using the EZ-CyTox kit (DAEIL LAB, Seoul, Korea). 3T3-L1 preadipocytes were seeded into 96-well cell culture plates at a density of 4 × 10 3 cells per well for 12 h at 37C. The cells were removed from the medium and treated with various concentrations of AAEO. After treatment for 24 h, 10 μL of EZ-CyTox reagent was added to each well, followed by incubation for 30 min at 37C. Cell viability was measured using an enzyme-linked immunosorbent assay reader (Synergy2, Biotek, USA) at 450 nm.
Oil red-O staining: Cells were washed 3 times with PBS and then fixed with 4% formaldehyde for 30 min. The fixed cells were washed 3 times with distilled water. 0.5% Oil red-O dye (Sigma) in 100% isopropanol was diluted with water (3:2), filtered through Whatman paper, and incubated with the fixed cells for 1 h at room temperature. Plates were rinsed 3 times with distilled water and the stained fat droplets in the adipocytes were visualized by light microscopy and photographed. Spectrophotometric analysis of the stain was performed by dissolving the stained lipid droplets with isopropanol and measuring at 520 nm.
Western blot: Cultured cells were washed 3 times with ice-cold PBS, and lysed using RIPA buffer (Cell signaling, Beverly, MA, USA) supplemented with protease inhibitors and phosphatase inhibitors (GenDEPOT, Barker, TX, USA). Protein (70 g) from the cell lysates was separated by electrophoresis on 810% sodium dodecyl sulfate-polyacrylamide gels and transferred onto a polyvinylidene fluoride membrane (Millipore, Bedford, MA, USA). The membranes were blocked by soaking in PBS buffer containing 3% nonfat dry milk for 2 h. The blocked membranes were probed overnight with each primary antibody, followed by incubation with secondary antibody for 1 h 30 min. The immunoreactive bands were visualized using a chemiluminescent substrate and exposed to photographic film.
Statistical analysis:
Data were expressed as the mean ± standard error of the mean (S.E.M.) in the indicated number of experiments. Statistical analysis of the data was performed using Student's t test for comparisons between pairs of groups using GraphPad prism (GraphPad Software, San Diego, CA, USA). P values < 0.05 were considered significant.
